Patent Assignment
Reel/Frame 027901/0253
Assignment of Assignor's Interest
Recorded: 2012-03-21
Pages: 4
Assignor
AMGEN INC.
Executed: 2008-03-04
Assignees
AMGEN INC.
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CALIFORNIA, 91320-1799
MEDAREX, INC.
707 STATE ROAD, SUITE 206, PRINCETON, NEW JERSEY, 08540
Covered Property
(1)
Methods of Treating Conditions Caused by Increased Expression of Nerve Growth Factor (Ngf) or Increased Sensitivity to Ngf Using Anti-Ngf Neutralizing Antibodies as Selective Ngf Pathway Inhibitors
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 21, 2012
From: WILD, KENNETH D., JR.; TREANOR, JAMES J.S.; HUANG, HAICHUN; INOUE, HEATHER
To: AMGEN INC.
Reel/Frame 027901/0231 →
Merger
Aug 15, 2013
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 031016/0678 →
Merger
May 22, 2015
From: MEDAREX, L.L.C.
To: E. R. SQUIBB & SONS, L.L.C.
Reel/Frame 035695/0204 →